Advisor Group Holdings, Inc. My Md Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.22 - $0.58 $198 - $522	-900 Reduced 11.54%	6,901 $1,000
Q3 2023 Nov 13, 2023	BUY	$0.47 - $1.87 $2,770 - $11,021	5,894 Added 309.07%	7,801 $4,000
Q3 2022 Nov 14, 2022	BUY	$2.22 - $82.2 $4,218 - $156,180	1,900 Added 27142.86%	1,907 $5,000
Q2 2022 Aug 10, 2022	BUY	$2.0 - $4.78 $12 - $28	6 Added 600.0%	7 $0
Q1 2022 May 04, 2022	SELL	$3.34 - $6.05 $364 - $659	-109 Reduced 99.09%	1 $0
Q3 2021 Nov 05, 2021	BUY	$4.64 - $7.94 $491 - $841	106 Added 2650.0%	110 $1,000
Q2 2021 Aug 02, 2021	BUY	$3.39 - $6.98 $13 - $27	4 New	4 $0

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.